214 related articles for article (PubMed ID: 28193417)
1. Development of nanostructured lipid carriers for the encapsulation and controlled release of vitamin D3.
Park SJ; Garcia CV; Shin GH; Kim JT
Food Chem; 2017 Jun; 225():213-219. PubMed ID: 28193417
[TBL] [Abstract][Full Text] [Related]
2. Encapsulation of vitamin D3 using rhamnolipids-based nanostructured lipid carriers.
Azevedo MA; Cerqueira MA; Gonçalves C; Amado IR; Teixeira JA; Pastrana L
Food Chem; 2023 Nov; 427():136654. PubMed ID: 37399642
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D3 cress seed mucilage -β-lactoglobulin nanocomplexes: Synthesis, characterization, encapsulation and simulated intestinal fluid in vitro release.
Taheri A; Kashaninejad M; Tamaddon AM; Jafari SM
Carbohydr Polym; 2021 Mar; 256():117420. PubMed ID: 33483012
[TBL] [Abstract][Full Text] [Related]
4. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
5. Nanostructured lipid carriers with exceptional gastrointestinal stability and inhibition of P-gp efflux for improved oral delivery of tilmicosin.
Zhang Q; Yang H; Sahito B; Li X; Peng L; Gao X; Ji H; Wang L; Jiang S; Guo D
Colloids Surf B Biointerfaces; 2020 Mar; 187():110649. PubMed ID: 31767412
[TBL] [Abstract][Full Text] [Related]
6. Enhanced antifungal activity of voriconazole-loaded nanostructured lipid carriers against
Tian B; Yan Q; Wang J; Ding C; Sai S
Int J Nanomedicine; 2017; 12():7131-7141. PubMed ID: 29026306
[No Abstract] [Full Text] [Related]
7. Improvement of curcuminoid bioaccessibility from turmeric by a nanostructured lipid carrier system.
Park SJ; Garcia CV; Shin GH; Kim JT
Food Chem; 2018 Jun; 251():51-57. PubMed ID: 29426423
[TBL] [Abstract][Full Text] [Related]
8. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
Song A; Zhang X; Li Y; Mao X; Han F
Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
[TBL] [Abstract][Full Text] [Related]
9. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers.
Wang W; Chen L; Huang X; Shao A
AAPS PharmSciTech; 2017 Feb; 18(2):509-516. PubMed ID: 27120090
[TBL] [Abstract][Full Text] [Related]
10. High payload nanostructured lipid carriers fabricated with alendronate/polyethyleneimine ion complexes.
Abd El-Hamid BN; Swarnakar NK; Soliman GM; Attia MA; Pauletti GM
Int J Pharm; 2018 Jan; 535(1-2):148-156. PubMed ID: 29104057
[TBL] [Abstract][Full Text] [Related]
11. Lipids-based nanostructured lipid carriers (NLCs) for improved oral bioavailability of sirolimus.
Yu Q; Hu X; Ma Y; Xie Y; Lu Y; Qi J; Xiang L; Li F; Wu W
Drug Deliv; 2016 May; 23(4):1469-75. PubMed ID: 27187522
[TBL] [Abstract][Full Text] [Related]
12. Nanostructured lipid carriers for the topical delivery of tretinoin.
Ghate VM; Lewis SA; Prabhu P; Dubey A; Patel N
Eur J Pharm Biopharm; 2016 Nov; 108():253-261. PubMed ID: 27519827
[TBL] [Abstract][Full Text] [Related]
13. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
Noor NM; Sheikh K; Somavarapu S; Taylor KMG
Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid modified nanostructured lipid carriers for transdermal bupivacaine delivery: In vitro and in vivo anesthesia evaluation.
Yue Y; Zhao D; Yin Q
Biomed Pharmacother; 2018 Feb; 98():813-820. PubMed ID: 29571251
[TBL] [Abstract][Full Text] [Related]
16. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
[TBL] [Abstract][Full Text] [Related]
17. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.
Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X
J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044
[TBL] [Abstract][Full Text] [Related]
18. Development of novel rosuvastatin nanostructured lipid carriers for oral delivery in an animal model.
Li J; Yang M; Xu W
Drug Des Devel Ther; 2018; 12():2241-2248. PubMed ID: 30050285
[TBL] [Abstract][Full Text] [Related]
19. Curcumin and genistein coloaded nanostructured lipid carriers: in vitro digestion and antiprostate cancer activity.
Aditya NP; Shim M; Lee I; Lee Y; Im MH; Ko S
J Agric Food Chem; 2013 Feb; 61(8):1878-83. PubMed ID: 23362941
[TBL] [Abstract][Full Text] [Related]
20. Implications of formulation design on lipid-based nanostructured carrier system for drug delivery to brain.
Salunkhe SS; Bhatia NM; Bhatia MS
Drug Deliv; 2016 May; 23(4):1306-16. PubMed ID: 25080227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
